Transperineal (TP) biopsies may be the hottest topic in the care of men on active surveillance for low- and favorable intermediate-risk prostate cancer.

ASPI (Active Surveillance Patients International) is holding a roundtable of experts to discuss transperineal vs. transrectal biopsies at noon Eastern Time April 24. Register at https://bit.ly/3g0vVzc

here will be a question-and-answer period  Send questions in advance to mlichty@ptd.net

The program will feature, among others:

—Dr. Ferdinand Becker, an AS patient who nearly died from sepsis caused by a transrectal biopsy.

—Dr. Rick Popert, a British self-proclaimed  “prostatologist,” who is among the leaders of the international TRexit (Exit Transrectal biopsies) movement.

—Dr. Matthew Allaway, a urologist who invented the PrecisionPoint ultrasound guide that is helping persuade urologists to switch to TP.

—Dr. Richard Szabo, of the University of California, Irvine, who has written extensively about the risks and costs of TP vs. TR.

—Jonah Rusere, a urology nurse at Guy’s Hospital in London, who is training other nurses to perform transperineal biopsies in the office.